| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID3357 |
| PMID | 22628229 |
| Peptide Sequence | NA |
| Peptide Sequence in Publication | NA |
| Protein Name | NA |
| UniprotKB Entry Name | NA |
| Biofluid | Serum |
| M/Z | 1012.61 |
| Charge | NA |
| Mass/H+ | NA |
| Mass (in Daltons) | NA |
| Profiling Technique | MALDI-TOF |
| Peptide Identification Technique | MS/MS |
| Quantification Technique | NA |
| Labeling | Label Free |
| FDR | NA |
| p-Value | less than 0.001 |
| Software | Flex analysis and ClinProTools |
| Length of Peptide | NA |
| Cancer Type | Non-small cell lung cancer (NSCLC) |
| Database for Peptide search | NA |
| Modification | NA |
| Number of Patients | 60 patients (28 for training set and 32 for testing set); 64 healthy (32 for training set and 32 for testing set) |
| Regulation/Differential Expression | Downregulated in cancer vs normal |
| Validation | Independent validation |
| Sensitivity | 97.5% on training data and 80.7% on testing data |
| Specificity | 98.8% on training data and 91.2% on testing data |
| Accuracy | NA |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | |